Drug makers AbbVie, Bristol Myers Squibb, Janssen, Lilly, and Merck asked a federal district court in South Carolina on Friday [...] …
Category: Judicial
Today is the first day of Louisiana’s new law protecting 340B program contract pharmacy arrangements and there have already been [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Health Resources and Services Administration (HRSA) still stands by its 340B program patient definition, the agency said in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district judge in Sacramento, Calif., recently dismissed a lawsuit aimed at reversing the state’s January 2022 transfer of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Apexus, the federally contracted 340B prime vendor, and AIDS Healthcare Foundation are meeting with a mediator to try to settle [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal health care officials can’t make a South Carolina health center obey their reading of the 340B patient definition for the same reason a federal appeals court said in January that the officials can’t force drug manufacturers to deliver 340B
…
Drug industry trade group Pharmaceutical Research and Manufacturers of America and drug manufacturer Bristol Myers Squibb have filed separate federal lawsuits to stop Medicare from negotiating the prices of some drugs, charging that it would impose unconstitutional price controls on
…
The U.S. Chamber of Commerce and three state and local affiliates are asking a federal court to strike down the part of the Inflation Reduction Act that lets Medicare negotiate “maximum fair prices” (MFPs) for some expensive, single-source drugs, arguing
…